Appearance and Shape (20°C) | Solid |
---|---|
CAS RN | 120511-73-1 |
MDL number | MFCD00866298 |
Molecular weight | 293.37 |
Molecular Formula | C17H19N5 |
Product code | ICTA2370 |
PubChem Substance ID | 135727309 |
Purity/Analytical Methods | >98.0%(T)(HPLC) |
Reaxys-RN | 8005958 |
Appearance | White to Almost white powder to crystal |
---|
Pictograms | |
---|---|
Hazard statement | H301 : Toxic if swallowed. |
Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant P270 : Do not eat, drink or smoke when using this product P264 : Wash skin thoroughly after handling P301 + P310 + P330 : IF SWALLOWED: Immediately call a POISON CENTER/doctor. Rinse mouth P405 : Store locked up. |
Signal word | Danger |
RTECS# | CZ1465000 |
---|
Category | 6.1 |
---|---|
Packaging category | III |
UN number | UN3439 |
Chemicals by Class 5-Membered Heterocyclic Compounds [Chemical Structural Class] Triazoles [Chemical Structural Class] 1,2,4-Triazoles [Chemical Structural Class]
Life Science Biochemicals and Reagents Enzymes, Enzyme Inhibitors, Enzyme Substrates Enzyme Inhibitors [Biochemicals and Reagents] Enzyme Inhibitors [A to C] Aromatase Inhibitors Enzyme Inhibitors by Enzyme Pharmaceutical Ingredients (for Research and Experimental Use) Antitumor Ingredients (for Research and Experimental Use) Hormonal Antitumor Agents Cell Biology Cancer Research Antitumor Agents Cytochrome P450 (CYP) Inhibitors Therapy Adjuncts [Antitumor Agents] Pharmaceutical Development and Drug Discovery Research Pharmaceutical Ingredients (for Research and Experimental Use) Antitumor Ingredients (for Research and Experimental Use) Hormonal Antitumor Agents